Declining locus coeruleus–dopaminergic and noradrenergic modulation of long-term memory in aging and Alzheimer's disease

MJ Dahl, A Kulesza, M Werkle-Bergner… - … & Biobehavioral Reviews, 2023 - Elsevier
Memory is essential in defining our identity by guiding behavior based on past experiences.
However, aging leads to declining memory, disrupting older adult's lives. Memories are …

[HTML][HTML] Noradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing

IF Orlando, JM Shine, TW Robbins, JB Rowe… - Neuroscience & …, 2023 - Elsevier
Noradrenergic and cholinergic systems are among the most vulnerable brain systems in
neuropsychiatric diseases of ageing, including Alzheimer's disease, Parkinson's disease …

A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment

AI Levey, D Qiu, L Zhao, WT Hu, DM Duong… - Brain, 2022 - academic.oup.com
The locus coeruleus is the initial site of Alzheimer's disease neuropathology, with
hyperphosphorylated Tau appearing in early adulthood followed by neurodegeneration in …

State-of-the-art imaging of neuromodulatory subcortical systems in aging and Alzheimer's disease: Challenges and opportunities

N Engels-Domínguez, EA Koops, PC Prokopiou… - Neuroscience & …, 2023 - Elsevier
Primary prevention trials have shifted their focus to the earliest stages of Alzheimer's disease
(AD). Autopsy data indicates that the neuromodulatory subcortical systems'(NSS) nuclei are …

[HTML][HTML] The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance

MJ Dahl, SL Bachman, S Dutt, S Düzel, NC Bodammer… - Nature Aging, 2023 - nature.com
Abstract Changes in dopaminergic neuromodulation play a key role in adult memory
decline. Recent research has also implicated noradrenaline in shaping late-life memory …

[HTML][HTML] Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau

M Van Egroo, JM Riphagen, NJ Ashton… - Molecular …, 2023 - nature.com
Autopsy data indicate that the locus coeruleus (LC) is one of the first sites in the brain to
accumulate hyperphosphorylated tau pathology, with the rostral part possibly being more …

Noradrenaline in the aging brain: promoting cognitive reserve or accelerating Alzheimer's disease?

M Mather - Seminars in cell & developmental biology, 2021 - Elsevier
Many believe that engaging in novel and mentally challenging activities promotes brain
health and prevents Alzheimer's disease in later life. However, mental stimulation may also …

[HTML][HTML] Noradrenaline in alzheimer's disease: A new potential therapeutic target

IL Gutiérrez, C Dello Russo, F Novellino… - International Journal of …, 2022 - mdpi.com
A growing body of evidence demonstrates the important role of the noradrenergic system in
the pathogenesis of many neurodegenerative processes, especially Alzheimer's disease …

[HTML][HTML] Prefrontal cortical connectivity mediates locus coeruleus noradrenergic regulation of inhibitory control in older adults

A Tomassini, FH Hezemans, R Ye… - Journal of …, 2022 - Soc Neuroscience
Response inhibition is a core executive function enabling adaptive behavior in dynamic
environments. Human and animal models indicate that inhibitory control and control …

[HTML][HTML] Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer's disease and Parkinson's disease

CP Lin, I Frigerio, JGJM Bol, MMA Bouwman… - Translational …, 2024 - Springer
Background Degeneration of the locus coeruleus (LC) noradrenergic system contributes to
clinical symptoms in Alzheimer's disease (AD) and Parkinson's disease (PD). Diffusion …